<code id='CAD1047584'></code><style id='CAD1047584'></style>
    • <acronym id='CAD1047584'></acronym>
      <center id='CAD1047584'><center id='CAD1047584'><tfoot id='CAD1047584'></tfoot></center><abbr id='CAD1047584'><dir id='CAD1047584'><tfoot id='CAD1047584'></tfoot><noframes id='CAD1047584'>

    • <optgroup id='CAD1047584'><strike id='CAD1047584'><sup id='CAD1047584'></sup></strike><code id='CAD1047584'></code></optgroup>
        1. <b id='CAD1047584'><label id='CAD1047584'><select id='CAD1047584'><dt id='CAD1047584'><span id='CAD1047584'></span></dt></select></label></b><u id='CAD1047584'></u>
          <i id='CAD1047584'><strike id='CAD1047584'><tt id='CAD1047584'><pre id='CAD1047584'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:38415

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Biogen Alzheimer’s drug launch off to slow start
          Biogen Alzheimer’s drug launch off to slow start

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSevenmonthsafterUSdrugregulatorsfullyapprovedBiogen’stre

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Roivant's CEO is a star, but biotech's black hole persists

          MollyFerguson/STATRoivantSciences’MattGlinemightbethisyear’sbestbiopharmaCEO,andotherthoughtsaboutMo